ARCHIVES

Autologous BMT Equivalent To Allogeneic For Myeloma

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Goldsmith Named CEO of CancerCare

April 11, 2014

Reports of SPOREs cut Premature, Broder Says, Wait for Peer Review

March 13, 1992

Amgen Announces Cochrane Findings: ESAs Increase Risk Of On-Study Death.

October 3, 2008

International Group Plans Survey On Thrombosis Risk

July 27, 2001

NCCS Networker Volume 8 Issue 4, Winter 1994

January 13, 1994

Obituary: Joan Mauer, 65, Chief, NCI Clinical Trials Monitoring Branch

October 15, 2010